2nd Quarter - Report
MILLER STRATEGIES, LLC for ALZHEON, INC.
Client
Income
$180,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Issues related to FDA drug approval process and therapies for Alzheimer's disease.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ASHLEY GUNN | — |
| JEFFREY MILLER | — |
| JAMES MIN | — |
Health Issues HCR
Issues related to FDA drug approval process and therapies for Alzheimer's disease.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ASHLEY GUNN | — |
| JEFFREY MILLER | — |
| JAMES MIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.